Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by sury – India, 2019-04-03 14:28 (1821 d 05:24 ago) – Posting: # 20117
Views: 4,303

Hii All,

Hope all are doing well....

Recently i have received to provide the sample size based on the Pharmacodynamic endpoints.

As we use the ISCV for the estimation of sample size in general Bioequivalence studies.

Can anyone have any idea how can we provide sample size for the PD endpopints


Responses are highly appreciated.:-)

Thanks all


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
94 visitors (0 registered, 94 guests [including 7 identified bots]).
Forum time: 18:53 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5